| | Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 PREDNISOLONE 16,17-DEHYDRO 21-HYDROXY PNS57 (8S,9S,10R,11S,13S,14S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-7,8,9,11,12,13,14,15-octahydro-6H-cyclopenta[a]phenanthren-3(10H)-one Group : 501841 Group : 501841 Group : 501841 Group : 501841 Prednisolone 21-Carboxylic Acid CAS:61549-70-0 PNS48 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetic acid Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Prednisolone Acetate EP Impurity E Deltacortinene Acetate CAS:4380-55-6 PSA05 2-((8S,10S,13S,14S,17R)-17-Hydroxy-10,13-dimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 PREGNENOLONE CAS:145-13-1 PNL00 1-((3S,8S,9S,10R,13S,14S,17S)-3-Hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone Group : 501841 PREGNENOLONE 16-DEHYDRO CAS:1162-53-4 PNL60 1-((3S,8R,9S,10R,13S,14S)-3-Hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone Group : 501841 PREGNENOLONE 17A-ACETOXY CAS:2381-45-5 PNL61 (3S,8R,9S,10R,13S,14S,17R)-17-Acetyl-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate Group : 501841 PREGNENOLONE 20A-DIHYDRO CAS:901-56-4 PNL62 (3S,8S,9S,10R,13S,14S)-17-((S)-1-Hydroxyethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol Group : 501841 Pregnenolone 20a-Dihydro 3-Sulfate Sodium CAS:131320-06-4 PNL63N Sodium (3S,8S,9S,10R,13S,14S)-17-((S)-1-hydroxyethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl sulfate Pregnenolone 20ß-Dihydro CAS:901-57-5 PNL64 (3S,8S,9S,10R,13S,14S,17S)-17-((R)-1-Hydroxyethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol Pregnenolone 20ß-Dihydro 3-Sulfate (Acid) CAS:19763-73-6 PNL65A (3S,8S,9S,10R,13S,14S)-17-((R)-1-Hydroxyethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl sulfuric acid Pregnenolone 20ß-Dihydro 3-Sulfate Sodium Salt PNL65N Sodium (3S,8S,9S,10R,13S,14S)-17-((R)-1-hydroxyethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl sulfate PREGNENOLONE 3-ISOBUTYRATE PNL66 (3S,8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl isobutyrate PREGNENOLONE 3-SULFATE (ACID) CAS:1247-64-9 PNL67A (3S,8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl sulfate acid Group : 501841 PREGNENOLONE 3-SULFATE SODIUM SALT CAS:1852-38-6 PNL67N Sodium (3S,8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl sulfate sodium salt Group : 501841 PREGNENOLONE 7,8-DEHYDRO CAS:1158830-87-5 PNL78 1-((3S,9S,10R,13S,14R,17S)-3-Hydroxy-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone Group : 501841 PREGNENOLONE ACETATE CAS:1778-02-5 PNL50 (3S,8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate Group : 501841 PREGNENOLONE ACETATE 16-DEHYDRO CAS:979-02-2 PNL53 (3S,9S,10R,13S,14S)-17-Acetyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate Group : 501841 PREGNENOLONE ACETATE 16-DEHYDRO 21-TRIFLATE PNL51 (3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(2-(trifluoromethylsulfonyloxy)acetyl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate PREGNENOLONE ACETATE 16-DEHYDRO OXIME CAS:2174-13-2 PNL52 (3S,8R,9S,10R,13S,14S)-17-((Z)-1-(Hydroxyimino)ethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate PREGNENOLONE CARBONITRILE CAS:1434-54-4 PNL68 (3S,8S,9S,10R,13S,14S,16R,17S)-17-Acetyl-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-16-carbonitrile Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 PRISTINAMYCIN IA CAS:3131-03-1 270076-60-3 (IA + IIA) PSM01A N-{22-[4-(Dimethylamino)benzyl]-6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyldocosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l] [1,4,7,10, 13,16] oxapentaazacyclononadecin-9-yl}-3-hydroxypyridine-2-carboxamide Group : 501841 Group : 501841 Pristinamycin IIA Virginiamycin M1 CAS:21411-53-0 270076-60-3 (IA + IIA) PSM02A 8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl) (3R,4R,5E,10E,12E,14S)-3H-21,18-nitrolo-1H,22H-pyrrolo[2,1-c][1,8,4,19]-dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 PROGESTERONE 6-KETO CAS:8/5/2243 PGR60 (8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-1,7,8,10,11,12,13,15,16,17-decahydro-2H-cyclopenta[a]phenanthrene-3,6(9H,14H)-dione PROGESTERONE 6A-HYDROXY CAS:604-20-6 PGR61 (6S,8S,9S,10R,13S,14S,17S)-17-Acetyl-6-hydroxy-10,13-dimethyl-1,7,8,10,11,12,13,15,16,17-decahydro-2H-cyclopenta[a]phenanthren-3(6H,9H,14H)-one Group : 501841 Progesterone 6ß-Hydroxy CAS:604-19-3 PGR62 (6R,8S,9S,10R,13S,14S,17S)-17-Acetyl-6-hydroxy-10,13-dimethyl-1,7,8,10,11,12,13,15,16,17-decahydro-2H-cyclopenta[a]phenanthren-3(6H,9H,14H)-one Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 PROMESTRIENE CAS:39219-28-8 PMS00 (8R,9S,13S,14S,17S)-17-Methoxy-13-methyl-3-propoxy-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene Group : 501841 Promestriene Dehydro Impurity Delta-9,11 Promestriene PMS50 (8S,13S,14S,17S)-17-Methoxy-13-methyl-3-propoxy-7,8,12,13,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthrene Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 PROPAFENONE LACTOSE ADDUCT PRP53 1-(2-(3-(((2R,3R,4R,5S,6R)-3,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)(propyl)amino)-2-hydroxypropoxy)phenyl)-3-phenylpropan-1-one Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Raltegravir RC 5 CAS:869901-69-9 RGV65 (6S)-2-(3-Chloro-4-fluorobenzyl)-8-ethyl-10-hydroxy-N,6-dimethyl-1,9-dioxo-1,2,6,7,8,9-hexahydropyrazino[1',2'1,5]pyrrolo[2,3-d]pyridazine-4-carboxamide Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 RAPAMYCIN 18-EPIMER (18S)-SIROLIMUS CAS:253431-35-5 RPM18 (1R,9S,12S,15R,16E,18S,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-[(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,?]hexatriaconta-16,24,26,28-tetra Rapamycin 30-O-Desmethyl Impurity Sirolimus 30-O-Desmethyl Impurity 7-O-Desmethyl Rapamycin 7-O-Demethyl Sirolimus CAS:151519-50-5 RPM30 (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18,30-Trihydroxy-12-[(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19-methoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,?] hexatriaconta-16,24,26,28-tetra Rapamycin Open-Ring Acid 34-Hydroxy Sirolimus Seco Rapamycin B CAS:185107-79-3 RPM34 [(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,20S,21R)-14,20-Dihydroxy-22-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15-docosatetraen-1-yl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]-2-oxoacetyl]-2-piper Group : 501841 Rapamycin Open-Ring Anhydro Acid Secorapamycin CAS:147438-27-5 RPM35A [2R-[2a,2(S*),3a,6ß[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E/Z,21R*,22(1S*,3R*,4R*)]]]-1-[Oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-me Group : 501841 Rapamycin Open-Ring Anhydro Acid Sodium Salt Secorapamycin Sodium CAS:148554-65-8 RPM35N [2R-[2a,2(S*),3a,6ß[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E/Z,21R*,22(1S*,3R*,4R*)]]]-1-[Oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-me Group : 501841 RAPAMYCIN SIROLIMUS CAS:53123-88-9 RPM00 (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-[(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,?]hexatriaconta-16,24,26,28-tetra Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Retapamulin RC 1 RTP61 (3aS,4R,5S,6R,8R,9R,9aR)-5-Hydroxy-4,6,9,10-tetramethyl-6-(oxiran-2-yl)-1-oxodecahydro-3a,9-propanocyclopenta[8]annulen-8-yl 2-((8-methyl-8-azabicyclo[3.2.1]octan-3-yl)thio)acetate Retapamulin RC 3 RTP63 (3aR,4R,5R,7S,8S,9R,9aS,12R)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((8-methyl-8-azabicyclo[3.2.1]oct-2-en-3-yl)thio)acetate Retapamulin RC 4 Retapamulin S-Oxide RTP64 (3aR,4R,5R,7S,8S,9R,9aS,12R)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((R)-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)sulfinyl)acetate Retapamulin RC 5 Retapamulin N-Oxide RTP65 3-((2-(((3aS,4R,5S,6S,8R,9R,9aR)-5-Hydroxy-4,6,9,10-tetramethyl-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen-8-yl)oxy)-2-oxoethyl)thio)-8-methyl-8-azabicyclo[3.2.1]octane 8-oxide Retapamulin RC 6 RTP66 (3aS,4R,5S,6S,8R,9R,9aR)-4,6,9,10-Tetramethyl-5-((methylsulfonyl)oxy)-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen-8-yl 2-((8-methyl-8-azabicyclo[3.2.1]octan-3-yl)thio)acetate Retapamulin RC 7 RTP67 (3aS,4R,5S,6S,8R,9R,9aR)-5-Hydroxy-4,6,9,10-tetramethyl-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen-8-yl 2-(((3aR,4R,5R,7S,8S,9R,9aS,12R)-5-(2-hydroxyacetoxy)-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-8-yl)ox Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 RIFABUTIN CAS:72559-06-9 RFB00 (9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,18,20-Trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-(2-methylpropyl)-5,10,26-trioxo-3,5,9,10-tetrahydrospiro[9,4-(epoxypentadeca[1,11,13]trienimino)-2H-furo[2',3'7,8]naphtho[1,2-d]imidazole-2,4' Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 RIFABUTIN N-OXIDE CAS:645406-37-7 RFB50 (9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-Spiro[9,4-(epoxypentadeca[1,11,13]trienimino)-2H-furo[2',3'7,8]naphth[1,2-d]imidazole-2,4'-piperidine]-5,10,26(3H,9H)-trione, 16-(acetyloxy)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-( Group : 501841 RIFAMPICIN CAS:13292-46-1 RFP00 (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[[(4-methylpiperazin-1-yl)imino]methyl]-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienimino)naphto[2,1-b]furan-21-yl acetate Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Rifamycin 3-Formyl 3-Formylrifampicin SV CAS:13292-22-3 RMC53 1,2-Dihydro-5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-8-carboxaldehyde 21-acetate Group : 501841 RIFAXIMIN CAS:80621-81-4 RFX00 (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23-Tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)[1]benzofuro[4,5-e] pyrido[1,2-a] benzimidazol-25-yl acetate Group : 501841 Group : 501841 RIFAXIMIN DESACETYL IMPURITY CAS:80621-88-1 RFX62 5,6,21,23,25-Pentahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a] benzimidazole-1,15(2H)-dione Group : 501841 Rifaximin EP Impurity B Rifamycin B Rifamycin EP Impurity A 4-O-Carboxymethyl Rifamycin CAS:13929-35-6 RFX02 [(1,2-Dihydro-5,6,17,19,21-pentahydroxy-23- methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-9-yl)oxy]acetic acid 21-acetate Group : 501841 Rifaximin EP Impurity C (Free Phenol) Rifamycin SV Rifamycin CAS:6998-60-3 RFX03A 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate Group : 501841 Rifaximin EP Impurity C (Sodium) Rifamycin SV Sodium Rifamycin Sodium CAS:14897-39-3 RFX03N 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate sodium salt Group : 501841 RIFAXIMIN EP IMPURITY D RIFAXIMIN Y RFX04 (2S,16Z,18E,20R,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,20, 21,23- Pentahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]-trienoimino)[1]benzofuro[4,5-e] pyrido[1,2-a]benzimidazol-25-yl acetate Group : 501841 Rifaximin EP Impurity E Rifamycin S Rifamycin EP Impurity B CAS:13553-79-2 RFX05 5,17,19,21-Tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13] trienimino)naphtho[2,1-b]furan-1,6,9,11(2H)-tetrone 21-Acetate Group : 501841 Group : 501841 Rifaximin EP Impurity G 6-O,14-Didehydro Rifaximin Dehydro Rifaximin CAS:80621-76-7 RFX07 (2S,7Z,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,21,23-Trihydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-1,6,15-trioxo-1,2,6,7-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienonitrilo)[1]benzofuro-[4,5-e]pyrido[1,2-a]benzimidazol-25-yl acetate RIFAXIMIN EP IMPURITY H 16-DESMETHYL-16-HYDROXYMETHYL RIFAXIMIN CAS:1210022-90-4 RFX08 (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23-Tetrahydroxy-16-(hydroxymethyl)-27-methoxy-2,4,11,20,22,24,26-heptamethyl-1,15-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13] trienoimino)[1]benzofuro-[4,5-e]pyrido[1,2-a]benzimidazol-25-yl acetat Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 Group : 501841 |